Study Condition(s): Migraine

A Study of Lasmiditan in Participants With Migraine

Study Alias: LAHC

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT03247790 {{ currentLocaleObject.registryAnchorText }}

Completed Completed

Study Purpose

The purpose of this study is to measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it during an acute migraine attack and also during the time between acute migraine attacks.

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

18+ years

Time Commitment

Your participation could last approximately 6 weeks and may include overnight stays
  • Participant must have a history of migraine with or without aura, for at least 1 year
  • Participant must not have participated in a clinical study involving an investigational product within the last 30 days
  • Participant must not have a history of or current irritable bowel syndrome
  • Participant must not have used or intend to use any migraine prevention treatments (including, but not limited to, propranolol or topiramate) within 30 days of the first dose of study drug and during the study

Where This Study Took Place Tool Tip Icon

3 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.